Changes in the ageing brain in health and disease
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The brains of individuals, who are cognitively normal, show age–related changes that include an overall reduction in brain volume and weight, which are associated with gyral atrophy and widening of the sulci of the cerebral cortex, and enlargement of the brain ventricles. These changes are partly the result of nerve cell loss but accurate estimates of neuronal loss are notoriously difficult to make. Microscopically, there are increasing amounts of the age–related pigment, lipofuscin, granulovacuolar degeneration in neurons, Hirano bodies, variable amounts of diffuse deposits of β–amyloid in the parenchyma, the presence of neurofibrillary tangles mainly confined to the hippocampus and amygdala, and sparse numbers of senile plaques in these brain regions and also in other cortical areas. Of these changes, neurofibrillary tangles and senile plaques are the neuropathological hallmark of Alzheimer's disease in which they are more abundant and widespread. Alzheimer's disease has therefore been regarded as accelerated brain ageing; however, the realization that there is a strong genetic contribution to developing the disease at least implies that it may not be the inevitable, even if frequent, consequence of old age. Understanding the molecular basis of plaque and tangle formation is advancing greatly and is the main focus of research into the cellular and molecular changes observed in the ageing brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 1×
“…compared to Ab40, as do cells transfected with mutant presenilins, and plasma from Alzheimer's patients possessing mutant presenilins also has relatively more Ab42 as do the brains from transgenic mice expressing such mutant presenilins (Scheuner et al. 1996; Du¡ et al. 1996; Borchelt et al. 1996).”
BackgroundAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“Most notably, mice transgenic for an APP minigene with one of the APP717 mutations develop neuritic plaques remarkably similar to those typical of Alzheimer's disease (Games et al. 1995).”
BackgroundBorchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · cited 1×
“Apolipoprotein E4 protein has been claimed to promote aggregation of Ab more strongly than apolipoprotein E3 (Strittmatter et al. 1993), but other studies have found the opposite e¡ect and this may depend upon the source of apolipoprotein E used for the experiments (LaDu et al. 1994).”
BackgroundGoedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036 · cited 1×
“…become `frozen' in a hyperphosphorylated state with phosphatases no longer able to remove phosphate, possibly because of aggregation of the tau into PHF which might be triggered by generation of a truly abnormally phosphorylated site or by factors such as proteoglycans (Goedert et al. 1996).”
BackgroundRelease of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor
Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913 · cited 1×
“…of APP at the three secretase sites, and indeed experimental studies using transfected cells has shown that the Swedish double mutation results in a 5^8 fold increase in secreted Ab (Cai et al. 1993) and the APP717 mutations result in an increase in the ratio of Ab42 : Ab40 (Suzuki et al. 1994).”
BackgroundNeuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772 · cited 1×
“The evidence suggests, however, that there is dendritic growth in the normal ageing brain and that this may be a compensatory mechanism for neuronal loss (Coleman & Flood 1987).”
Background
Cited by
von Bartheld, C. S., Bahney, J., & Herculano‐Houzel, S. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24040 · Cited by 1,063
“…Fall-Out”, Brody, 1955; Hanley, 1974; Devaney and Johnson, 1980; Curcio et al., 1982) has been refuted, primarily through Haug’s pioneering work and others’ (Haug et al., 1984; Haug, 1987; Terry et al., 1987; West, 1993b; Anderton, 1997; see also “Examples showing impact of cell counting,” below).”
BackgroundValenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 784
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
Driscoll, I., Davatzikos, C., An, Y., Wu, X., Shen, D., Kraut, M., & Resnick, S. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a82634 · Cited by 532
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Facial expression recognition across the adult life span
Calder, A. J., Keane, J., Manly, T., Sprengelmeyer, R., Scott, S., Nimmo-Smith, I., & Young, A. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00149-5 · Cited by 390
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
“It is known that small amounts of Ab is deposited in the normal brain (Anderton, 1997) and in the normal retina, and the levels of these deposits increase with increasing age.”
BackgroundAlpha-synuclein, lipids and Parkinson’s disease
Ruipérez, V., Darios, F., & Davletov, B. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.004 · Cited by 231
Anderton, B. H. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00426-2 · Cited by 187
Self-citation
Metadata
- Authors
- Anderton, B. H.
- Venue
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 1997-12-29
- Volume
- 352
- Issue
- 1363
- Pages
- 1781-1792
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2096547809
- Cited by
- 77
- References
- 26
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.